Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Deep learning-based reconstruction (DLR) can reduce the radiation dose associated with low-dose chest and abdominal CT scans without sacrificing image quality, according to a new study published in the American Journal of Roentgenology.
The American Society of Radiologic Technologists (ASRT) has published a new white paper on AI and its potential impact on the work of medical imaging and radiation therapy professionals.
Machine learning (ML) algorithms can be trained to predict acute kidney injury (AKI) in burn and trauma patients within the first 24 hours, according to a new study published in Scientific Reports.
Civica Rx, the startup drug company founded by health foundations, is teaming up with Thermo Fisher Scientific in a seven-year agreement to develop and manufacture medications, with Civica serving as the owner of the regulatory pathway.
